JP2018509151A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018509151A5 JP2018509151A5 JP2017547412A JP2017547412A JP2018509151A5 JP 2018509151 A5 JP2018509151 A5 JP 2018509151A5 JP 2017547412 A JP2017547412 A JP 2017547412A JP 2017547412 A JP2017547412 A JP 2017547412A JP 2018509151 A5 JP2018509151 A5 JP 2018509151A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- polypeptide
- item
- cells
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020168936A JP6970991B2 (ja) | 2015-03-11 | 2020-10-06 | トランスポザーゼポリペプチド及びその使用 |
| JP2021173757A JP2022025097A (ja) | 2015-03-11 | 2021-10-25 | トランスポザーゼポリペプチド及びその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562131827P | 2015-03-11 | 2015-03-11 | |
| US62/131,827 | 2015-03-11 | ||
| PCT/US2016/021693 WO2016145146A1 (en) | 2015-03-11 | 2016-03-10 | Transposase polypeptides and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020168936A Division JP6970991B2 (ja) | 2015-03-11 | 2020-10-06 | トランスポザーゼポリペプチド及びその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018509151A JP2018509151A (ja) | 2018-04-05 |
| JP2018509151A5 true JP2018509151A5 (https=) | 2019-04-18 |
| JP6775515B2 JP6775515B2 (ja) | 2020-10-28 |
Family
ID=55587385
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017547412A Active JP6775515B2 (ja) | 2015-03-11 | 2016-03-10 | トランスポザーゼポリペプチド及びその使用 |
| JP2020168936A Active JP6970991B2 (ja) | 2015-03-11 | 2020-10-06 | トランスポザーゼポリペプチド及びその使用 |
| JP2021173757A Withdrawn JP2022025097A (ja) | 2015-03-11 | 2021-10-25 | トランスポザーゼポリペプチド及びその使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020168936A Active JP6970991B2 (ja) | 2015-03-11 | 2020-10-06 | トランスポザーゼポリペプチド及びその使用 |
| JP2021173757A Withdrawn JP2022025097A (ja) | 2015-03-11 | 2021-10-25 | トランスポザーゼポリペプチド及びその使用 |
Country Status (17)
| Country | Link |
|---|---|
| US (4) | US10570382B2 (https=) |
| EP (2) | EP3268470B1 (https=) |
| JP (3) | JP6775515B2 (https=) |
| KR (1) | KR102615825B1 (https=) |
| CN (1) | CN107532174A (https=) |
| AU (2) | AU2016229094B2 (https=) |
| CA (1) | CA2977818A1 (https=) |
| DK (1) | DK3268470T3 (https=) |
| ES (1) | ES2854675T3 (https=) |
| HU (1) | HUE053368T2 (https=) |
| IL (2) | IL285286B2 (https=) |
| MX (2) | MX388517B (https=) |
| PL (1) | PL3268470T3 (https=) |
| RU (2) | RU2735700C2 (https=) |
| SG (1) | SG11201707111RA (https=) |
| WO (1) | WO2016145146A1 (https=) |
| ZA (1) | ZA201706420B (https=) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9458450B2 (en) | 2012-03-15 | 2016-10-04 | Flodesign Sonics, Inc. | Acoustophoretic separation technology using multi-dimensional standing waves |
| US10704021B2 (en) | 2012-03-15 | 2020-07-07 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
| US10967298B2 (en) | 2012-03-15 | 2021-04-06 | Flodesign Sonics, Inc. | Driver and control for variable impedence load |
| US9950282B2 (en) | 2012-03-15 | 2018-04-24 | Flodesign Sonics, Inc. | Electronic configuration and control for acoustic standing wave generation |
| EP3783098A1 (en) | 2013-05-14 | 2021-02-24 | Board Of Regents, The University Of Texas System | Human application of engineered chimeric antigen receptor (car) t-cells |
| WO2015105955A1 (en) | 2014-01-08 | 2015-07-16 | Flodesign Sonics, Inc. | Acoustophoresis device with dual acoustophoretic chamber |
| KR102375998B1 (ko) | 2014-02-14 | 2022-03-21 | 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 | 키메라 항원 수용체 및 제조방법 |
| CA2964783C (en) | 2014-11-05 | 2024-01-23 | Board Of Regents, The University Of Texas System | Chimeric antigen receptors (car) to selectively target protein complexes |
| US10808230B2 (en) | 2015-02-24 | 2020-10-20 | Board Of Regents, The University Of Texas System | Selection methods for genetically-modified T cells |
| KR102615825B1 (ko) | 2015-03-11 | 2023-12-21 | 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 | 전위효소 폴리펩타이드 및 이의 용도 |
| US11708572B2 (en) | 2015-04-29 | 2023-07-25 | Flodesign Sonics, Inc. | Acoustic cell separation techniques and processes |
| US11021699B2 (en) | 2015-04-29 | 2021-06-01 | FioDesign Sonics, Inc. | Separation using angled acoustic waves |
| US11377651B2 (en) | 2016-10-19 | 2022-07-05 | Flodesign Sonics, Inc. | Cell therapy processes utilizing acoustophoresis |
| US11459540B2 (en) | 2015-07-28 | 2022-10-04 | Flodesign Sonics, Inc. | Expanded bed affinity selection |
| US11474085B2 (en) | 2015-07-28 | 2022-10-18 | Flodesign Sonics, Inc. | Expanded bed affinity selection |
| HK1258218A1 (zh) | 2015-09-15 | 2019-11-08 | Board Of Regents, The University Of Texas System | T细胞受体(tcr)结合抗体及其应用 |
| EP3368075B1 (en) | 2015-10-27 | 2020-01-29 | Board of Regents, The University of Texas System | Chimeric antigen receptor molecules and uses thereof |
| US11085035B2 (en) | 2016-05-03 | 2021-08-10 | Flodesign Sonics, Inc. | Therapeutic cell washing, concentration, and separation utilizing acoustophoresis |
| US11214789B2 (en) | 2016-05-03 | 2022-01-04 | Flodesign Sonics, Inc. | Concentration and washing of particles with acoustics |
| CA3025667A1 (en) | 2016-06-08 | 2017-12-14 | Intrexon Corporation | Cd33 specific chimeric antigen receptors |
| WO2018075830A1 (en) | 2016-10-19 | 2018-04-26 | Flodesign Sonics, Inc. | Affinity cell extraction by acoustics |
| EP3568474A1 (en) | 2017-01-10 | 2019-11-20 | Intrexon Corporation | Modulating expression of polypeptides via new gene switch expression systems |
| US11629340B2 (en) | 2017-03-03 | 2023-04-18 | Obsidian Therapeutics, Inc. | DHFR tunable protein regulation |
| EP3673053A1 (en) | 2017-08-21 | 2020-07-01 | EMBL European Molecular Biology Laboratory | Improved transposase polypeptide and uses thereof |
| KR102439221B1 (ko) | 2017-12-14 | 2022-09-01 | 프로디자인 소닉스, 인크. | 음향 트랜스듀서 구동기 및 제어기 |
| KR20250136930A (ko) | 2018-03-06 | 2025-09-16 | 프레시전 인코포레이티드 | 사람 파필로마바이러스 백신 및 이의 용도 |
| IL277128B2 (en) | 2018-03-06 | 2025-11-01 | Precigen Inc | Hepatitis b vaccines and uses of the same |
| WO2020168086A1 (en) * | 2019-02-13 | 2020-08-20 | Geerlings Maurits W | Nanocarriers for the delivery of nucleic acids and uses thereof |
| JP7769325B2 (ja) | 2019-07-23 | 2025-11-13 | 株式会社東芝 | Ｃａｒ－ｔ細胞の製造方法、核酸導入キャリア及びキット |
| WO2021050789A1 (en) | 2019-09-10 | 2021-03-18 | Obsidian Therapeutics, Inc. | Ca2-il15 fusion proteins for tunable regulation |
| EP4127184A4 (en) * | 2020-03-30 | 2024-04-24 | Institute Of Zoology, Chinese Academy Of Sciences | Active dna transposon systems and methods for use thereof |
| EP4271817A2 (en) | 2020-12-30 | 2023-11-08 | Alaunos Therapeutics, Inc. | Recombinant vectors comprising polycistronic expression cassettes and methods of use thereof |
| WO2022183167A1 (en) | 2021-02-25 | 2022-09-01 | Alaunos Therapeutics, Inc. | Recombinant vectors comprising polycistronic expression cassettes and methods of use thereof |
| US20250145950A1 (en) | 2022-02-01 | 2025-05-08 | Alaunos Therapeutics, Inc. | Methods for Activation and Expansion of T Cells |
| CN118638859A (zh) * | 2024-05-10 | 2024-09-13 | 中国科学院动物研究所 | 活性dna转座子系统及其使用方法 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| US4690915A (en) | 1985-08-08 | 1987-09-01 | The United States Of America As Represented By The Department Of Health And Human Services | Adoptive immunotherapy as a treatment modality in humans |
| US5925545A (en) * | 1996-09-09 | 1999-07-20 | Wisconsin Alumni Research Foundation | System for in vitro transposition |
| ATE466948T1 (de) | 1997-03-11 | 2010-05-15 | Univ Minnesota | Dns-basiertes transposon-system für die einführung von nucleinsäure in die dns einer zelle |
| US6410319B1 (en) | 1998-10-20 | 2002-06-25 | City Of Hope | CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignancies |
| EP1234781B1 (de) * | 1999-06-02 | 2004-09-15 | Alcan Technology & Management AG | Kindersichere Verpackung für Tabletten |
| WO2003089618A2 (en) * | 2002-04-22 | 2003-10-30 | Regents Of The University Of Minnesota | Transposon system and methods of use |
| CA2534639C (en) | 2003-07-31 | 2013-07-30 | Immunomedics, Inc. | Anti-cd19 antibodies |
| US20060026699A1 (en) | 2004-06-04 | 2006-02-02 | Largaespada David A | Methods and compositions for identification of genomic sequences |
| EP2160461B1 (en) | 2007-07-04 | 2012-08-08 | Max-Delbrück-Centrum für Molekulare Medizin (MDC) | Hyperactive variants of the transposase protein of the transposon system sleeping beauty |
| WO2010008564A2 (en) * | 2008-07-16 | 2010-01-21 | Recombinetics | Plaice dna transposon system |
| AU2010206374B2 (en) | 2009-01-23 | 2013-01-17 | Gloriana Therapeutics Sarl | Improved cell lines and their use in encapsulated cell biodelivery |
| JP2014511704A (ja) | 2011-04-13 | 2014-05-19 | イミュニカム・エイビイ | Ｔ細胞のプライミングのための方法 |
| US10391126B2 (en) | 2011-11-18 | 2019-08-27 | Board Of Regents, The University Of Texas System | CAR+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLA |
| DK3456734T3 (da) | 2012-10-04 | 2022-04-19 | Res Found Dev | Serinproteasemolekyler og behandlinger |
| EP3783098A1 (en) | 2013-05-14 | 2021-02-24 | Board Of Regents, The University Of Texas System | Human application of engineered chimeric antigen receptor (car) t-cells |
| CA2913052A1 (en) | 2013-05-24 | 2014-11-27 | Board Of Regents, The University Of Texas System | Chimeric antigen receptor-targeting monoclonal antibodies |
| EP3060059A4 (en) | 2013-10-25 | 2017-11-01 | Board of Regents, The University of Texas System | Polyclonal gamma delta t cells for immunotherapy |
| KR102375998B1 (ko) | 2014-02-14 | 2022-03-21 | 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 | 키메라 항원 수용체 및 제조방법 |
| CA2945388A1 (en) | 2014-04-23 | 2015-10-29 | Board Of Regents, The University Of Texas System | Chimeric antigen receptors (car) for use in therapy and methods for making the same |
| KR20200138445A (ko) | 2014-04-24 | 2020-12-09 | 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 | 입양 세포 요법 생성물을 생성하기 위한 유도 만능 줄기 세포의 응용 |
| US20170333480A1 (en) | 2014-11-05 | 2017-11-23 | Board Of Regents, The University Of Texas System | Gene modified immune effector cells and engineered cells for expansion of immune effector cells |
| CA2964783C (en) | 2014-11-05 | 2024-01-23 | Board Of Regents, The University Of Texas System | Chimeric antigen receptors (car) to selectively target protein complexes |
| US10808230B2 (en) | 2015-02-24 | 2020-10-20 | Board Of Regents, The University Of Texas System | Selection methods for genetically-modified T cells |
| KR102615825B1 (ko) * | 2015-03-11 | 2023-12-21 | 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 | 전위효소 폴리펩타이드 및 이의 용도 |
| HK1258218A1 (zh) | 2015-09-15 | 2019-11-08 | Board Of Regents, The University Of Texas System | T细胞受体(tcr)结合抗体及其应用 |
| EP3368075B1 (en) | 2015-10-27 | 2020-01-29 | Board of Regents, The University of Texas System | Chimeric antigen receptor molecules and uses thereof |
-
2016
- 2016-03-10 KR KR1020177027114A patent/KR102615825B1/ko active Active
- 2016-03-10 WO PCT/US2016/021693 patent/WO2016145146A1/en not_active Ceased
- 2016-03-10 SG SG11201707111RA patent/SG11201707111RA/en unknown
- 2016-03-10 EP EP16711096.4A patent/EP3268470B1/en active Active
- 2016-03-10 MX MX2017011679A patent/MX388517B/es unknown
- 2016-03-10 PL PL16711096T patent/PL3268470T3/pl unknown
- 2016-03-10 RU RU2017134741A patent/RU2735700C2/ru active
- 2016-03-10 HU HUE16711096A patent/HUE053368T2/hu unknown
- 2016-03-10 ES ES16711096T patent/ES2854675T3/es active Active
- 2016-03-10 CN CN201680017179.9A patent/CN107532174A/zh active Pending
- 2016-03-10 AU AU2016229094A patent/AU2016229094B2/en not_active Ceased
- 2016-03-10 EP EP20204973.0A patent/EP3851523A1/en not_active Withdrawn
- 2016-03-10 RU RU2020127887A patent/RU2020127887A/ru unknown
- 2016-03-10 CA CA2977818A patent/CA2977818A1/en active Pending
- 2016-03-10 JP JP2017547412A patent/JP6775515B2/ja active Active
- 2016-03-10 US US15/556,868 patent/US10570382B2/en active Active
- 2016-03-10 DK DK16711096.4T patent/DK3268470T3/da active
- 2016-03-10 IL IL285286A patent/IL285286B2/en unknown
-
2017
- 2017-09-10 IL IL254394A patent/IL254394B/en unknown
- 2017-09-11 MX MX2021014712A patent/MX2021014712A/es unknown
- 2017-09-22 ZA ZA2017/06420A patent/ZA201706420B/en unknown
-
2020
- 2020-01-14 US US16/742,571 patent/US10883094B2/en active Active
- 2020-04-20 AU AU2020202653A patent/AU2020202653B2/en not_active Ceased
- 2020-10-06 JP JP2020168936A patent/JP6970991B2/ja active Active
- 2020-11-24 US US17/103,500 patent/US11492604B2/en active Active
-
2021
- 2021-10-25 JP JP2021173757A patent/JP2022025097A/ja not_active Withdrawn
-
2022
- 2022-10-26 US US18/049,944 patent/US12116604B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018509151A5 (https=) | ||
| Zander et al. | Tfh-cell-derived interleukin 21 sustains effector CD8+ T cell responses during chronic viral infection | |
| RU2017134741A (ru) | Полипептиды транспозазы и их применение | |
| JP7733865B2 (ja) | 強化されたｈＡＴファミリーのトランスポゾンが介在する遺伝子導入ならびに関連する組成物、システム、及び方法 | |
| CN110730821B (zh) | 增强的hAT家族转座子介导的基因转移及相关组合物、系统和方法 | |
| Peperzak et al. | CD8+ T cells produce the chemokine CXCL10 in response to CD27/CD70 costimulation to promote generation of the CD8+ effector T cell pool | |
| JP7852942B2 (ja) | 活性ｄｎａトランスポゾンシステム及びその使用方法 | |
| JP2022530653A (ja) | Ｔｅｔ２改変ｔ細胞療法を使用するがんの治療のための組成物及び方法 | |
| Bolinger et al. | Adenoviral vector vaccination induces a conserved program of CD8+ T cell memory differentiation in mouse and man | |
| JP2021518160A5 (https=) | ||
| Selich et al. | Umbilical cord as a long-term source of activatable mesenchymal stromal cells for immunomodulation | |
| CN107794272A (zh) | 一种高特异性的crispr基因组编辑体系 | |
| JP2014520551A5 (https=) | ||
| JP6022470B2 (ja) | 分散型タンパク質形質導入ドメインを含む誘導性発現系転写モジュレータおよびその使用方法 | |
| Chakravarti et al. | Inducible gene switches with memory in human T cells for cellular immunotherapy | |
| JP7728755B2 (ja) | 細胞を再プログラム化して形質細胞様樹状細胞またはｉ型インターフェロン産生細胞に変換する組成物、その方法および用途 | |
| Haertle et al. | Identification of the receptor and cellular ortholog of the Marek's disease virus (MDV) CXC chemokine | |
| KR20220105161A (ko) | 항원 제시를 위해 세포를 2형 수지상 세포 성분으로 재프로그래밍하기 위한 조성물, 그 방법 및 용도 | |
| Serra et al. | Engineering of human mesenchymal stem/stromal cells with vascular endothelial growth factor–encoding minicircles for angiogenic ex vivo gene therapy | |
| Kazantseva et al. | A mouse model of the Δ133p53 isoform: roles in cancer progression and inflammation | |
| JP2021510080A (ja) | Ｔ細胞に高い転写活性を有するキメラプロモーター | |
| CN112899238A (zh) | 基于RNA-m6A修饰水平的化合物筛选细胞模型及其构建与应用 | |
| WO2025232868A1 (zh) | 活性dna转座子系统及其使用方法 | |
| CN104711240B (zh) | 禽呼肠孤病毒σA蛋白及其相关生物材料的应用 | |
| Kust et al. | Functional analysis of Drosophila HSP70 promoter with different HSE numbers in human cells |